Penumbra (PEN) Other financing activities (2014 - 2026)
Penumbra (PEN) posted quarterly Other financing activities of $9.7 million for Q2 2026, up 44.3% year-over-year from $6.7 million in Q2 2025, and up 839.22% quarter-over-quarter from $1.0 million in Q4 2025.
Penumbra (PEN) Other financing activities (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Other financing activities for 13 consecutive years, with $9.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other financing activities rose 44.3% year-over-year to $9.7 million; the TTM figure through Jun 2026 stood at $15.4 million (down 10.54% YoY), while the FY2025 annual figure was $16.4 million, up 7.23% from the prior year.
- Other financing activities improved to $9.7 million in Q2 2026 per PEN's latest filing, from $1.0 million in the prior quarter.
- Across five years, Other financing activities topped out at $9.7 million in Q2 2026 and bottomed at $238000.0 in Q1 2024.
- Historically, Other financing activities has averaged $5.0 million across 5 years, with a median of $6.0 million in 2022.
- Annual changes were most pronounced in 2024 — Other financing activities sank 89.23% — and 2025, when it surged 1589.92%.
- Penumbra's Other financing activities stood at $5.8 million in 2022, then grew by 12.88% to $6.5 million in 2023, then retreated by 1.09% to $6.4 million in 2024, then plunged by 84.01% to $1.0 million in 2025, then jumped by 839.22% to $9.7 million in 2026.
- Business Quant data shows PEN's Other financing activities at $9.7 million in Q2 2026, $1.0 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Penumbra | 12.79 Bn | 12.13 Bn | 264.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.67 Mn |
| Jun 30, 2026 | 9.67 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Dec 31, 2024 | -8.92 Mn |
| Dec 31, 2024 | -8.92 Mn |
| Sep 30, 2024 | 8.92 Mn |
| Sep 30, 2024 | 8.92 Mn |
| Mar 31, 2024 | -61,000.00 |
| Mar 31, 2024 | -61,000.00 |
| Dec 31, 2023 | -4.81 Mn |
| Dec 31, 2023 | -4.81 Mn |
| Sep 30, 2023 | 4.81 Mn |
| Sep 30, 2023 | 4.81 Mn |